Edition:
United States

People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

49.90USD
29 Jul 2016
Change (% chg)

$1.77 (+3.68%)
Prev Close
$48.13
Open
$49.00
Day's High
$50.06
Day's Low
$48.28
Volume
1,435,697
Avg. Vol
1,133,870
52-wk High
$80.71
52-wk Low
$27.14

Frates, James 

Mr. James M. Frates is Chief Financial Officer, Senior Vice President of Alkermes Plc. Prior to assuming his current position, from May 2007 to September 16, 2011, Mr. Frates served as Senior Vice President and Chief Financial Officer of Alkermes, Inc. From June 1998 to May 2007, Mr. Frates served as Vice President, Chief Financial Officer and Treasurer of Alkermes, Inc. From June 1996 to June 1998, he was employed at Robertson, Stephens & Company, most recently as a Vice President in Investment Banking. Prior to that time he was employed at Morgan Stanley & Co. Mr. Frates serves on the Board of Directors of Sage Therapeutics, a publicly traded biotechnology company. Mr. Frates served on the board of directors of GPC Biotech AG, a biotechnology company, from June 2004 to 2009, and was a national director of the Association of Bioscience Financial Officers from 2004 to 2009. Mr. Frates is also a Trustee of St. Paul's School.

Basic Compensation

Total Annual Compensation, USD 468,727
Restricted Stock Awards, USD 530,550
Long-Term Incentive Plans, USD --
All Other, USD 1,566,120
Fiscal Year Total, USD 2,565,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 114,296 1,347,350.00
Name Fiscal Year Total

Richard Pops

10,448,400

Shane Cooke

4,646,970

James Frates

2,565,400

Gordon Pugh

1,965,720

Kathryn Biberstein

3,041,000

Elliot Ehrich

3,188,760
As Of  30 Dec 2014